Applied Nutrition founders sell £19M stake in first placing since IPO
What's the deal? Applied Nutrition's two largest individual shareholders, Thomas Ryder and Steven Granite, have agreed to sell 7,000,000 ordinary shares at 275 pence each, raising £19,250,000. The stake represents about 2.80% of the sports nutrition company's issued share capital.
Why now? It is the first sale by the pair since Applied Nutrition's October 2024 IPO. The company said the placing "diversifies their asset base."
What's the endgame? Applied Nutrition is not party to the placing and will receive no proceeds. After completion, Ryder remains its largest shareholder with 81,162,494 shares, or 32.46% of the company.
Panmure LiberumDealroom has a profile for this one. Try Dealroom → acted as sole bookrunner. The trade date is September 11, 2026, with settlement expected on September 15, 2026.
What could go wrong? Founder sell-downs can weigh on sentiment. To limit that, the selling shareholders agreed not to dispose of further shares for 180 days after completion, subject to certain exceptions.
The signal: Post-IPO secondary placings let founders realise value without new dilution to the company. Ryder's retained third of the register signals continued alignment even as he trims his holding.
Read more: investegate.co.uk
Image credit: nenad53
